Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label pharmacokinetic comparison of Accordion Pill carbidopa/levodopa versus immediate-release Sinemet in Parkinson's disease
2018-001209-95Phase 2Completed
- Sponsor
- Intec Pharma Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of carbidopa + levodopa in Parkinson's disease (PD) (2 arms), sponsored by Intec Pharma Ltd. Primary endpoint: Levodopa fluctuation index. Started Aug 2021; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2018-001209-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001209-95.